Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of One Lot of Firvanq® (Vancomycin Hydrochloride for Oral Solution), Vancomycin 50 mg/mL Kit, Due to a Mix-Up of the Diluent Included in the Kit

Date: 09/08/2021

Product type: Drugs, Unapproved Ingredient

Company Announcement Date: September 08, 2021
FDA Publish Date: September 08, 2021
Product Type: Drugs
Reason for Announcement: Product kit may contain incorrect diluent.
Company Name: Azurity Pharmaceuticals, Inc.
Brand Name: Azurity
Product Description: Firvanq

US-FDA Link: